Publications by authors named "Darko Mitrovic"

Three proton-sensing G protein-coupled receptors (GPCRs)-GPR4, GPR65, and GPR68-respond to extracellular pH to regulate diverse physiology. How protons activate these receptors is poorly understood. We determined cryogenic-electron microscopy (cryo-EM) structures of each receptor to understand the spatial arrangement of proton-sensing residues.

View Article and Find Full Text PDF
Article Synopsis
  • Mutations in transporters, specifically looking at the OCT1 liver transporter, can influence drug responses and contribute to various diseases.
  • The study analyzed over 11,000 variants in OCT1 using advanced techniques like saturation mutagenesis and multi-phenotypic screening, discovering that many variants mainly affect the protein's abundance rather than its function.
  • The research created detailed models of how these variants impact the transport cycle of OCT1, offering insights for predicting how genetic variations affect drug response and disease susceptibility.
View Article and Find Full Text PDF

Background And Objective: Topical clindamycin formulations are widely used in clinical practice, but poor bioavailability and restricted skin penetration considerably limit their therapeutic efficacy. Penetration enhancement represents a promising and rational strategy to overcome the drawbacks of conventional topical pharmaceutical formulations. We aim to assess the influence of cholic acid (CA) and deoxycholic acid (DCA) on the permeability of clindamycin hydrochloride by performing the in vitro skin parallel artificial membrane permeability assay (skin-PAMPA) at two relevant pH values (5.

View Article and Find Full Text PDF

Despite its beneficial pharmacological effects in the brain, partly by modulating inositol phosphate multikinase (IPMK) activity, the therapeutic use of quercetin is limited due to its poor solubility, low oral bioavailability, and low permeability through the blood-brain barrier (BBB). We aimed to identify quercetin analogues with improved BBB permeability and preserved binding affinities towards IPMK and to identify the molecular characteristics required for them to permeate the BBB. Binding affinities of quercetin analogues towards IPMK were determined by molecular docking.

View Article and Find Full Text PDF

With the advent of AI-powered structure prediction, the scientific community is inching closer to solving protein folding. An unresolved enigma, however, is to accurately, reliably, and deterministically predict alternative conformational states that are crucial for the function of, e.g.

View Article and Find Full Text PDF

Sugar porters (SPs) represent the largest group of secondary-active transporters. Some members, such as the glucose transporters (GLUTs), are well known for their role in maintaining blood glucose homeostasis in mammals, with their expression upregulated in many types of cancers. Because only a few sugar porter structures have been determined, mechanistic models have been constructed by piecing together structural states of distantly related proteins.

View Article and Find Full Text PDF

In mammals, glucose transporters (GLUT) control organism-wide blood-glucose homeostasis. In human, this is accomplished by 14 different GLUT isoforms, that transport glucose and other monosaccharides with varying substrate preferences and kinetics. Nevertheless, there is little difference between the sugar-coordinating residues in the GLUT proteins and even the malarial transporter HT1, which is uniquely able to transport a wide range of different sugars.

View Article and Find Full Text PDF
Article Synopsis
  • Membrane transporters are crucial for how drugs and natural compounds are distributed in the body, affecting both their effectiveness and potential side effects; variations in these transporters among individuals can lead to different responses to medications.* -
  • The study focuses on the Human organic cation transporter OCT1, examining how specific genetic variations impact its ability to transport drugs, primarily by affecting protein folding rather than the actual uptake of substances.* -
  • The findings also indicate that the prevalence of reduced-function variants differs among populations, with implications for precision medicine, as certain genetic variations may be linked to conditions like high LDL cholesterol.*
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated how well Dutch hospitals follow protocols for using reversal agents in patients on direct oral anticoagulants (DOAC).
  • It included data from 290 patients and found moderate adherence (61%) for bleeding cases involving prothrombin complex concentrate (PCC) and higher adherence (96%) for idarucizumab.
  • Urgent procedures showed low adherence (45%) for PCC and 0% for andexanet alfa, mainly due to underdosing, lack of indication, and missing lab data.
View Article and Find Full Text PDF

Objectives: To investigate and describe the protocolized perioperative management in patient using Direct oral anticoagulants (DOACs) in Dutch hospitals.

Methods: Between August and December 2020, a nationwide survey in 70 hospitals in the Netherlands was conducted. We asked hospital pharmacists to submit their protocols for perioperative management of DOAC (apixaban, dabigatran, edoxaban and rivaroxaban) users.

View Article and Find Full Text PDF

Objective: To investigate and describe the protocolized treatment of DOAC-related bleeds in all Dutch hospitals.

Methods: From August to December 2020 a nationwide survey among all 70 hospitals in the Netherlands was conducted on their protocols for management of bleeding in patients treated with direct oral anticoagulants (DOACs, i.e.

View Article and Find Full Text PDF

What Is Known And Objective: Many severe intoxications occur with substances with no specific antidote, which is why methods of extracorporeal elimination represent a particularly useful and even critical component in their management. The purpose of this review is to summarize the accumulating evidence and clinical results from the application of CytoSorb hemoadsorption therapy in patients with severe intoxications.

Comment: The technology represents a promising technique with an increasing number of publications in a variety of severe intoxication scenarios suggesting that early intervention might provide rapid substance removal with subsequent overall clinical improvement.

View Article and Find Full Text PDF

A weak notion of solution for systems of conservation laws in one dimension is put forward. In the framework introduced here, it can be shown that the Cauchy problem for any system of conservation laws has a solution. The solution concept is an extension of the notion of singular -shocks which have been used to provide solutions for Riemann problems in various systems, for example in cases where strict hyperbolicity or the genuine-nonlinearity condition are not satisfied, or in cases where initial conditions have large variation.

View Article and Find Full Text PDF

Background And Objective: Several cases of venous thromboembolism in patients treated with direct oral anticoagulants (DOACs) have been reported in the literature, but a quantative analysis of postmarketing reports is lacking. The objective of this study was to determine the post-marketing odds ratio (OR) and reporting odds ratio (ROR) of venous thromboembolism in patients receiving DOACs compared among each other and to vitamin K antagonists (VKAs).

Methods: The OR and ROR were used to determine the ratio of reports for deep vein thrombosis and pulmonary embolism between 1 January, 2012 and 15 November, 2020 using the World Health Organization VigiLyze database.

View Article and Find Full Text PDF

Objective: In a previous study on the reasons for discontinuation of novel oral anticoagulation therapy (NOAC) in patients with atrial fibrillation, we showed that minor bleeding was the second most important reason for NOAC discontinuation. This finding suggest that the impact of minor bleeds on the patient's perspective on NOACs cannot be ignored, especially those minor bleeds for which the patient searched medical care. We therefore performed a study in which we explored the impact of minor bleed (clinically relevant non-major bleeds) on patient confidence in therapy, adherence to treatment and quality of life in AF patients using NOAC's.

View Article and Find Full Text PDF

Background: A very common side effect of non-vitamin K antagonist oral anticoagulant (NOAC) is (minor) bleeding. Data about impact and costs of minor bleeds in NOAC therapy is still limited or not present in current literature. In this patient orientated study, we aim to provide an estimate of the costs of minor bleeds in patients with atrial fibrillation (AF) treated with a NOAC.

View Article and Find Full Text PDF

Motivated by the fact that the fractional Laplacean generates a wider choice of the interpolation curves than the Laplacean or bi-Laplacean, we propose a new non-local partial differential equation inspired by the Cahn-Hilliard model for recovering damaged parts of an image. We also note that our model is linear and that the computational costs are lower than those for the standard Cahn-Hilliard equation, while the inpainting results remain of high quality. We develop a numerical scheme for solving the resulting equations and provide an example of inpainting showing the potential of our method.

View Article and Find Full Text PDF

Aims: We sought to investigate the magnitude of minor bleeding and identify risk factors for minor bleeds during non-vitamin-K antagonist oral anticoagulant (NOAC) therapy.

Methods: This was an observational cohort study of patients with atrial fibrillation (AF) referred to a regional NOAC outpatient clinic between February 2013 and October 2017. The study population consisted of 875 consecutive patients with AF who visited the NOAC outpatient unit to initiate treatment with apixaban ( = 303), dabigatran ( = 267) or rivaroxaban ( = 305) for long-term ischemic stroke prophylaxis.

View Article and Find Full Text PDF

We sought to investigate the reasons for, and rates of, novel oral anticoagulant (DOAC) therapy discontinuation. This was an observational cohort study of patients with atrial fibrillation (AF) referred to a regional DOAC outpatient clinic between February 2013 and October 2017. The study population consisted of 875 consecutive patients with AF who visited the DOAC outpatient unit to initiate treatment with apixaban ( = 303), dabigatran ( = 267) or rivaroxaban ( = 305) for long-term ischemic stroke prophylaxis.

View Article and Find Full Text PDF